- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02176785
The Effect of Pre-Frontal tDCS on Sleep Propensity During an Afternoon Nap: RCT
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recent studies have demonstrated that there are cortical direct current (DC) changes that accompany sleep onset and transitions between sleep states in a stereotyped manner. In these studies it was determined that negative potential shifts occurred prior to and at the transition from wakefulness to sleep and at transitions between Rapid Eye Movement sleep (REM) sleep, and Non-Rapid Eye Movement (NREM) sleep. In a subset of experiments it was demonstrated that the same DC potential shifts occur during the transition from wake to sleep in an afternoon nap. The recorded DC potential shifts occurred predominantly in the pre-frontal cortex (F3, F4), with spread into central areas. No current literature exists that explores whether tDCS could be used to modulate cortical activity prior to sleep, resulting in either increased or decreased sleep propensity.
The application of focal, non-invasive brain stimulation has already led to novel and effective treatments for neuropsychiatric disease with minimal side effects (Most well studied in depression and repetitive Transcranial Magnetic Stimulation or, rTMS). Should the application of tDCS modulate sleep propensity it would represent a novel study paradigm with the potential to lead to a completely novel treatment for sleep disturbance. With this small pilot study, we propose taking the first step in exploring the utility of tDCS in modulating sleep propensity. We propose to recruit 15 healthy non-treatment seeking participants from the community and expose them to three total nap conditions in a randomized counter balanced fashion, with 10 minutes of either, Anodal, Cathodal, or Sham tDCS stimulation occurring prior to each nap opportunity.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29401
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18-65
- capable of coming in for an initial intake screen, and then again for 2 hours on consecutive Monday, Wednesday, and Friday afternoons
Exclusion Criteria:
- Presence of Neurologic, psychiatric, or sleep disorder.
- Current use of medications affecting the central nervous system.
- Daily consumption of alcohol, or consequences of alcohol use (DUI, occupational, or social dysfunction ect.).
- Tobacco use.
- Consumption of more than the equivalent of 300mg of caffeine daily.
- Habitual sleep duration of less than 6 ½ hours, greater than 8 ½ hours, a difference between weeknight, and weekend sleep of greater than 3 hours, or typical sleep timing more than 3 hours outside of the window of 10pm-6am.
- Score of greater than 5 on the Pittsburgh Sleep Quality Index (PSQ-I), or 10 on the Epworth Sleepiness scale (ESS).
- BMI greater than 30, or Heavy snoring.
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Sham tDCS
tDCS will be applied, but then turned off after 30 seconds.
|
tDCS will be delivered using a Chattanooga Ionto™ Iontophoresis System - Phoresor.
Other Names:
|
|
Experimental: Anodal tDCS 2mA 10 Minutes
Anodal tDCS will be applied bi-frontally for 10 minutes at 2mA
|
tDCS will be delivered using a Chattanooga Ionto™ Iontophoresis System - Phoresor.
Other Names:
|
|
Experimental: Cathodal tDCS 2mA 10 Minutes
Cathodal tDCS will be applied Bi-Frontally for 10 minutes at 2mA
|
tDCS will be delivered using a Chattanooga Ionto™ Iontophoresis System - Phoresor.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep onset latency and sleep architecture
Time Frame: 30 Minutes
|
Sleep onset latency and sleep architecture will be assessed using polysomnography during a 30 minute nap opportunity.
|
30 Minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep quality
Time Frame: 30 Minutes
|
Sleep quality will be assessed with a visual analog scale following each nap opportunity.
|
30 Minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Power Nap
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
Clinical Trials on transcranial Direct Current Stimulation (tDCS)
-
Charite University, Berlin, GermanyTerminatedNeuralgia | Neuropathic PainGermany
-
Manhattan Psychiatric CenterCompletedSchizophrenia | Auditory HallucinationUnited States
-
D'Or Institute for Research and EducationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Massachusetts General HospitalRecruitingAttention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
Oslo University HospitalCompleted
-
Education University of Hong KongThe University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist...Recruiting
-
Trustees of Dartmouth CollegeRecruitingWe Are Not Studying a Disease or ConditionUnited States
-
NYU Langone HealthNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingDepressionUnited States
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Charles University, Czech RepublicRecruiting